Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of potent, selective, orally active benzoxazepine-based Orexin-2 receptor antagonists
Tatsuhiko Fujimoto, Jun Kunitomo, Yoshihide Tomata, et al.
Bioorganic & Medicinal Chemistry Letters (2011) Vol. 21, Iss. 21, pp. 6414-6416
Closed Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

The role of orexin in motivated behaviours
Takeshi Sakurai
Nature reviews. Neuroscience (2014) Vol. 15, Iss. 11, pp. 719-731
Closed Access | Times Cited: 414
The Discovery of Suvorexant, the First Orexin Receptor Drug for Insomnia
Paul J. Coleman, Anthony L. Gotter, W. Joseph Herring, et al.
The Annual Review of Pharmacology and Toxicology (2016) Vol. 57, Iss. 1, pp. 509-533
Closed Access | Times Cited: 113
Orexin Receptor Antagonists: New Therapeutic Agents for the Treatment of Insomnia
Anthony J. Roecker, Christopher D. Cox, Paul J. Coleman
Journal of Medicinal Chemistry (2015) Vol. 59, Iss. 2, pp. 504-530
Closed Access | Times Cited: 107
TAK-925, an orexin 2 receptor-selective agonist, shows robust wake-promoting effects in mice
Hiroshi Yukitake, Tatsuhiko Fujimoto, Takashi Ishikawa, et al.
Pharmacology Biochemistry and Behavior (2019) Vol. 187, pp. 172794-172794
Closed Access | Times Cited: 83
Orexin receptors as therapeutic drug targets
Anthony L. Gotter, Anthony J. Roecker, Richard Hargreaves, et al.
Progress in brain research (2012), pp. 163-188
Closed Access | Times Cited: 95
The Hypocretin/Orexin System: An Increasingly Important Role in Neuropsychiatry
Quanhui Chen, Luı́s de Lecea, Zhian Hu, et al.
Medicinal Research Reviews (2014) Vol. 35, Iss. 1, pp. 152-197
Closed Access | Times Cited: 79
Selective orexin receptor antagonists
Terry P. Lebold, Pascal Bonaventure, Brock T. Shireman
Bioorganic & Medicinal Chemistry Letters (2013) Vol. 23, Iss. 17, pp. 4761-4769
Closed Access | Times Cited: 73
A Synthetic Overview of Benzoxazines and Benzoxazepines as Anticancer Agents
I. Chatterjee, Kasim Ali, Gautam Panda
ChemMedChem (2023) Vol. 18, Iss. 5
Closed Access | Times Cited: 18
Discovery of 5′′‐Chloro‐N‐[(5,6‐dimethoxypyridin‐2‐yl)methyl]‐2,2′:5′,3′′‐terpyridine‐3′‐carboxamide (MK‐1064): A Selective Orexin 2 Receptor Antagonist (2‐SORA) for the Treatment of Insomnia
Anthony J. Roecker, Swati P. Mercer, John D. Schreier, et al.
ChemMedChem (2013) Vol. 9, Iss. 2, pp. 311-322
Closed Access | Times Cited: 62
Effects of a newly developed potent orexin-2 receptor-selective antagonist, compound 1 m, on sleep/wakefulness states in mice
Keishi Etori, Yuki Saito, Natsuko Tsujino, et al.
Frontiers in Neuroscience (2014) Vol. 8
Open Access | Times Cited: 53
Toward an Understanding of Agonist Binding to Human Orexin-1 and Orexin-2 Receptors with G-Protein-Coupled Receptor Modeling and Site-Directed Mutagenesis
Alexander Heifetz, Oliver Barker, G. Benjamin Morris, et al.
Biochemistry (2013) Vol. 52, Iss. 46, pp. 8246-8260
Open Access | Times Cited: 42
Study of Human Orexin-1 and -2 G-Protein-Coupled Receptors with Novel and Published Antagonists by Modeling, Molecular Dynamics Simulations, and Site-Directed Mutagenesis
Alexander Heifetz, G. Benjamin Morris, Philip C. Biggin, et al.
Biochemistry (2012) Vol. 51, Iss. 15, pp. 3178-3197
Closed Access | Times Cited: 41
Orexin OX2 Receptor Antagonists as Sleep Aids
Laura H. Jacobson, Sui Chen, Sanjida Mir, et al.
Current topics in behavioral neurosciences (2016), pp. 105-136
Open Access | Times Cited: 35
Seven-Membered Rings
John H. Ryan, Christopher J. T. Hyland, Adam G. Meyer, et al.
Progress in heterocyclic chemistry (2012), pp. 493-536
Closed Access | Times Cited: 33
Synthesis, anti-cancer evaluation of benzenesulfonamide derivatives as potent tubulin-targeting agents
Jun Yang, Simin Yang, Shanshan Zhou, et al.
European Journal of Medicinal Chemistry (2016) Vol. 122, pp. 488-496
Closed Access | Times Cited: 29
Discovery of MK-3697: A selective orexin 2 receptor antagonist (2-SORA) for the treatment of insomnia
Anthony J. Roecker, Thomas S. Reger, M. Christa Mattern, et al.
Bioorganic & Medicinal Chemistry Letters (2014) Vol. 24, Iss. 20, pp. 4884-4890
Closed Access | Times Cited: 28
Long‐Range Diastereoselectivity in an Ugi Reaction: Stereocontrolled and Diversity‐Oriented Synthesis of Tetrahydrobenzoxazepines
Luca Banfi, Alessandro Bagno, Andrea Basso, et al.
European Journal of Organic Chemistry (2013) Vol. 2013, Iss. 23, pp. 5064-5075
Closed Access | Times Cited: 25
Discovery of 2,5-diarylnicotinamides as selective orexin-2 receptor antagonists (2-SORAs)
Swati P. Mercer, Anthony J. Roecker, Susan L. Garson, et al.
Bioorganic & Medicinal Chemistry Letters (2013) Vol. 23, Iss. 24, pp. 6620-6624
Closed Access | Times Cited: 24
Design, synthesis, and structure–activity relationships of a series of novel N-aryl-2-phenylcyclopropanecarboxamide that are potent and orally active orexin receptor antagonists
Yu Yoshida, Taro Terauchi, Yoshimitsu Naoe, et al.
Bioorganic & Medicinal Chemistry (2014) Vol. 22, Iss. 21, pp. 6071-6088
Closed Access | Times Cited: 20
Synthesis of new benzo[f]imidazo[1,2-d][1,4]oxazepines: AgNO3-mediated intramolecular hydroamination
Mohammad Mahdavi, Roshanak Hariri, Mina Saeedi, et al.
Tetrahedron Letters (2015) Vol. 56, Iss. 51, pp. 7082-7084
Closed Access | Times Cited: 18
Discovery of diazepane amide DORAs and 2-SORAs enabled by exploration of isosteric quinazoline replacements
Anthony J. Roecker, Swati P. Mercer, Jeffrey M. Bergman, et al.
Bioorganic & Medicinal Chemistry Letters (2015) Vol. 25, Iss. 21, pp. 4992-4999
Closed Access | Times Cited: 16
Orexin Receptor Antagonists in Development for Insomnia and CNS Disorders
Scott D. Kuduk, Christopher J. Winrow, Paul J. Coleman
Annual reports in medicinal chemistry (2013), pp. 73-87
Closed Access | Times Cited: 11
Seven-membered rings
Adam G. Meyer, Alex C. Bissember, Christopher J. T. Hyland, et al.
Progress in heterocyclic chemistry (2021), pp. 565-614
Closed Access | Times Cited: 9
Stereodivergent access to all four stereoisomers of chiral tetrahydrobenzo[f][1,4]oxazepines, through highly diastereoselective multicomponent Ugi–Joullié reaction
Alessandro Pinna, Andrea Basso, Chiara Lambruschini, et al.
RSC Advances (2020) Vol. 10, Iss. 2, pp. 965-972
Open Access | Times Cited: 9
Targeting the orexinergic system: Mainly but not only for sleep-wakefulness therapies
Abdelaziz Ghanemi, Xintian Hu
Alexandria Journal of Medicine (2014) Vol. 51, Iss. 4, pp. 279-286
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top